🇺🇸 FDA
Patent

US 9504742

Compositions for stimulation of mammalian innate immune resistance to pathogens

granted A61KA61K2039/54A61K2039/55516

Quick answer

US patent 9504742 (Compositions for stimulation of mammalian innate immune resistance to pathogens) held by The Board of Regents of the University of Texas System expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/54, A61K2039/55516, A61K2039/55561, A61K31/7125